Home / Diabetes In Control (page 308)

Diabetes In Control

Pendiq

Pendiq

Pendiq  The next generation in insulin pens comes to Europe first as they use pens 5-8 times more than the U.S. does. The pen can deliver dosages with a minimum dose of 2.0 units and increments of 0.1Units can be made. The Pendiq insulin pen is operated with common 3ml insulin …

Read More »

An A1c of 5.7% Indicates Greater Heart Risk

Researchers found participants with normal glucose tolerance but A1C rates between 5.7% and 6.4% had increased intima-media thickness and augmentation and augmentation index, suggesting that an A1C threshold of 5.7% may help better identify patients at greater cardiovascular risk. "These results suggest that an HbA1c cutoff of 5.7% is more …

Read More »

Albiglutide (FDA Application Pending) Has Greater Tolerability, Comparable A1c Reductions, But Less Weight Loss

Research showed type 2 diabetes patients who took once-weekly albiglutide attained significant reductions in A1C, comparable with those who were on once-daily liraglutide. "The data indicate that albiglutide is a reasonable alternative to other glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of diabetes. Researchers said that, "It has good …

Read More »